Kolexia
Goutorbe Felix Gastro-entérologie
Goutorbe Felix
Gastro-entérologie
Centre Hospitalier de la Côte Basque
Bayonne, France
65 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Nécrose Sténose pathologique Sténose du défilé gastrique Pochite Ictère

Collaborateurs

Voir plus
Buisson Anthony
Buisson Anthony
Hôpital Estaing, Clermont-Ferrand, France
Bommelaer Gilles
Bommelaer Gilles
Hôpital Estaing, Clermont-Ferrand, France
Audemar Franck
Audemar Franck
Centre Hospitalier de la Côte Basque, Bayonne, France
Nivet Dorothee
Nivet Dorothee
Centre Hospitalier de la Côte Basque, Bayonne, France

Industries

Voir plus
Janssen
23 collaboration(s)
Dernière en 2023
Abbvie
19 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
9 collaboration(s)
Dernière en 2023
Biogen
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
Inflammatory bowel diseases   05 avril 2023
P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
Deeper: STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP
Essai Clinique (CHU Clermont-Ferrand)   19 avril 2022
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
Journal of Crohn's & colitis   01 septembre 2021
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   24 décembre 2020
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study.
Alimentary pharmacology & therapeutics   07 décembre 2020
Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study.
Alimentary pharmacology & therapeutics   22 mars 2020
P447 No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy
Abstracts of the 15th Congress of ECCO Vienna, Austria, February 12–15, 2020   15 janvier 2020
P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)
Abstracts of the 15th Congress of ECCO Vienna, Austria, February 12–15, 2020   15 janvier 2020
Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease.
World journal of gastroenterology   02 décembre 2019